Prognostic factor | Category | n | Median (months) | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|---|---|---|
Hazard ratio | 95% CI | p value* | Hazard ratio | 95% CI | p value** | ||||
Age (years) | ≦ 70 | 43 | 17.0 | 1.00 | 0.35 - 1.03 | 0.062 | |||
>70 | 35 | 22.7 | 0.60 | ||||||
PSA at DTX initiation (ng/ml) | ≦ 20 | 39 | 39.6 | 1.00 | 1.94 - 6.11 | <0.001 | 1.00 | 0.058 | |
>20 | 39 | 12.6 | 3.44 | 2.07 | 0.98 - 4.37 | ||||
PSADT (months) | >2.4 | 38 | 31.4 | 1.00 | 1.48 - 4.41 | 0.001 | 1.00 | 0.033 | |
≦ 2.4 | 40 | 16.7 | 2.56 | 1.88 | 1.05 - 3.36 | ||||
ECOG performance status | ≦ 1 | 68 | 20.3 | 1.00 | 1.55 - 6.26 | 0.001 | 1.00 | 0.740 | |
2 | 10 | 4.1 | 3.11 | 1.16 | 0.49 - 2.74 | ||||
Gleason score | ≦ 7 | 21 | 31.2 | 1.00 | 0.89 - 3.00 | 0.113 | |||
>8 | 57 | 18.2 | 1.63 | ||||||
Armstrong risk classification | Good | 51 | 30.1 | 1.00 | 1.00 | 0.060 | |||
Intermediate | 17 | 14.2 | 2.48 | 1.32 - 4.66 | <0.001 | 1.33 | 0.60 - 2.97 | 0.487 | |
Poor | 10 | 5.7 | 6.58 | 3.07 - 14.11 | 3.21 | 1.17 - 8.80 | 0.024 |